Back to Results

Rubicon Organics Inc (ROMJF)

Rubicon Organics Inc. is a common stock listing on OTC Markets for a company focused on organic cannabis production, processing, and sales. Through its subsidiaries, the business serves both recreational and medical-use markets in Canada and international markets. Its product lineup spans a range of formats, including jars, bags, pre-rolls, edibles, milled flower, soft gels, hash, gummies, vape products, flower packs, and topical or oil-based items. The company markets these products under brands such as Simply Bare Organic, 1964 Supply Co, Homestead Cannabis Supply, LAB THEORY, and Wildflower. Incorporated in 2015 and based in Vancouver, Canada, the company was formerly known as West Coast Land Corporation and adopted its current name in May 2018.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-ROMJ.F
$0.29
-6.9% Downside
Fair
Not available
Not available
Good
0.0%
November 16, 2026
0.7x
0.5x
22.651 M
29.43 M
32.3%
62.8%
2.2
441.9%
Valuation • Fair Value

Rubicon Organics Inc (OTC-ROMJ.F) Fair Value by Valuation Model

Review the available estimates for Rubicon Organics Inc (OTC-ROMJ.F), including EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$0.29

Estimated downside of 6.9% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

EPV Fair Value

$0.23

Earnings power value estimate.

Comps Fair Value

$0.30

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 4 available valuation references for Rubicon Organics Inc (OTC-ROMJ.F) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Rubicon Organics Inc (OTC-ROMJ.F)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

45.287 M

Current operating scale indicator.

Revenue Forecast

53.248 M

Forward revenue estimate.

EBITDA

1.789 M

Current operating profitability reference.

EBITDA Forecast

3.568 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Rubicon Organics Inc (OTC-ROMJ.F) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Rubicon Organics Inc (OTC-ROMJ.F)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

2

Weak quality score that deserves closer review.

Beneish M-Score

-2.47

No elevated caution signal from this screen.

Altman Z-Score

2.2

Intermediate risk zone.

FCF / Net Income

441.9%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Rubicon Organics Inc (OTC-ROMJ.F). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Rubicon Organics Inc (OTC-ROMJ.F)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 16, 2026

Days to Earnings

10

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Rubicon Organics Inc (OTC-ROMJ.F), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Rubicon Organics Inc (OTC-ROMJ.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Rubicon Organics Inc (OTC-ROMJ.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Rubicon Organics Inc (OTC-ROMJ.F) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Rubicon Organics Inc (OTC-ROMJ.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Rubicon Organics Inc (OTC-ROMJ.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Rubicon Organics Inc (OTC-ROMJ.F) Stock FAQ

Data-supported answers about Rubicon Organics Inc (OTC-ROMJ.F), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.29
Estimated downside 6.9%
Valuation Rating
Overvalued
Estimated downside of 6.9%
Financial Health
Good
Current financial-health read

The current fair value estimate for Rubicon Organics Inc (OTC-ROMJ.F) is $0.29. This implies an estimated downside of 6.9% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 6.9% versus the current market price.

The current financial health read for Rubicon Organics Inc (OTC-ROMJ.F) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Rubicon Organics Inc (OTC-ROMJ.F) is November 16, 2026.

The latest available data indicates no current dividend yield for Rubicon Organics Inc (OTC-ROMJ.F).

The current market capitalization listed for Rubicon Organics Inc is 22.651 M.

The current enterprise value listed for Rubicon Organics Inc is 29.43 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Rubicon Organics Inc is OTC-ROMJ.F, and the stock is listed on OTC Markets.

Rubicon Organics Inc (OTC-ROMJ.F) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Rubicon Organics Inc is 32.3%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Rubicon Organics Inc is 62.8%. Free float helps investors understand how much of the share base is available for public trading.

Similar Pharmaceuticals Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

LLY NYSE Eli Lilly and Company Fair Value Fair Market Cap 1,215.6 B
JNJ NYSE Johnson & Johnson Fair Value Fair Market Cap 655.6 B
MRK NYSE Merck & Company Inc Fair Value Fair Market Cap 362.2 B
NVS NYSE Novartis AG ADR Fair Value Fair Market Cap 310 B
NVO NYSE Novo Nordisk A/S Fair Value Bargain Market Cap 179.5 B
PFE NYSE Pfizer Inc Fair Value Fair Market Cap 170.3 B
BMY NYSE Bristol-Myers Squibb Company Fair Value Fair Market Cap 129 B
SNY NASDAQ Sanofi ADR Fair Value Undervalued Market Cap 113.6 B
GSK NYSE GSK plc DRC Fair Value Undervalued Market Cap 101.9 B
TAK NYSE Takeda Pharmaceutical Co Ltd ADR Fair Value Fair Market Cap 69.723 B
TEVA NYSE Teva Pharma Industries Ltd ADR Fair Value Fair Market Cap 48.75 B
HLN NYSE HALEON PLC ADR Fair Value Undervalued Market Cap 40.368 B
RPRX NASDAQ Royalty Pharma Plc Fair Value Fair Market Cap 38.751 B
ZTS NYSE Zoetis Inc Fair Value Undervalued Market Cap 33.93 B
VTRS NASDAQ Viatris Inc Fair Value Fair Market Cap 21.789 B
JAZZ NASDAQ Jazz Pharmaceuticals PLC Fair Value Undervalued Market Cap 14.59 B
RDY NYSE Dr. Reddy’s Laboratories Ltd ADR Fair Value Fair Market Cap 11.996 B
ELAN NYSE Elanco Animal Health Fair Value Overvalued Market Cap 11.831 B
CORT NASDAQ Corcept Therapeutics Incorporated Fair Value Fair Market Cap 7.834 B
AXSM NASDAQ Axsome Therapeutics Inc Fair Value Undervalued Market Cap 6.827 B